Press Releases ASIT biotech CINNOBER BOAT

Equities

0RGO

BE0974289218

End-of-day quote CINNOBER BOAT Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-.--%

2023	DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DMS Imaging : Résultats annuels 2023 et chiffre d’affaires du 1er trimestre 2024	04-18	PU
Dms Imaging : DMS IMAGING : End of the ongoing procedure with Thierry Legon and reinstatement of the judicial reorganization plan homologated on February 9, 2021.	23/05/23	AT
Dms Imaging : Record quarterly revenue: EUR 10.1 million in the 1st quarter of 2023, organic growth +16% - Confirmation of 2023 targets and perspectives	20/04/23	AT
Dms Imaging : 2022 revenue: EUR 35.3 m - 2023 targets and perspectives	20/01/23	AT
Dms Imaging : Fujifilm Healthcare Italy wins tender for 96 X-ray tables, designed and produced by DMS Imaging	12/01/23	AT
Dms Imaging : 2022 bi-annual results	03/10/22	AT
DMS Imaging : Annual Financial Report 2021	01/08/22	PU
DMS Imaging: Publication Regarding a Transparency Notification	28/02/22	BU
ASIT biotech : 2020 annual financial report	30/04/21	PU
Egg Allergy Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight \| Aimmune Therapeutics, DBV Technologies, ASIT Biotechand Others.	16/04/21	AQ
ASIT biotech : presents its 2020 half year results and provides a business update until end 2020	30/09/20	PU
ASIT biotech : 2020 interim financial report as of June 30, 2020	30/09/20	PU
ASIT biotech : Presents Its 2020 Half Year Results and Provides a Business Update Until End 2020	30/09/20	BU
ASIT biotech : Annexe 1bis - cash position (french only)	20/09/20	PU
ASIT biotech : Obtains the Benefit of the Judicial Reorganization by Collective Agreement	12/02/20	BU
ASIT biotech : Reintroduces an Application for Judicial Reorganization and Modifies the Composition of Its Board of Directors	20/01/20	BU
ASIT biotech : Discloses Next Steps Following gp-ASIT+TM Phase III Results	20/12/19	BU
ASIT biotech : mode of action study of gp-ASIT+™ for grass pollen allergy published in The Journal of Allergy and Clinical Immunology (JACI)	17/10/19	PU
ASIT biotech Mode of Action Study of gp-ASIT+™ for Grass Pollen Allergy Published in The Journal of Allergy and Clinical Immunology (JACI)¹	17/10/19	GL
ASIT biotech Receives GMP Certification for its Manufacturing Site in Liège, Belgium	07/10/19	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ASIT biotech CINNOBER BOAT

Equities

0RGO

BE0974289218

Press Releases

Filters